These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 668724)

  • 41. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH; MacIntyre DE; Olverman HJ
    Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diversity of agonist-mediated signal transduction pathways in human platelets.
    Saeed SA; Shah BH
    Adv Exp Med Biol; 1997; 407():531-5. PubMed ID: 9322003
    [No Abstract]   [Full Text] [Related]  

  • 43. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
    Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
    Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased platelet aggregation and release reaction in myotonic dystrophy.
    Bornstein NM; Zahavi M; Korczyn AD; Zahavi J
    J Neurol Sci; 1988 Apr; 84(2-3):239-46. PubMed ID: 2967890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of canine platelet function II. Catecholamines.
    Meyers KM; Huston LY; Clemmons RM
    Am J Physiol; 1983 Jul; 245(1):R100-9. PubMed ID: 6869571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional expression of the amplification reaction between serotonin and epinephrine on platelets.
    De Clerck F; Xhonneux B; de Chaffoy de Courcelles D
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S1-5. PubMed ID: 2459505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro.
    Menys VC
    Cardiovasc Res; 1993 Nov; 27(11):1916-9. PubMed ID: 8287397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants.
    Xiao H; Harvey K; Labarrere CA; Kovacs R
    Cryobiology; 2000 Sep; 41(2):97-105. PubMed ID: 11034788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
    Born GV; Juengjaroen K; Michal F
    Br J Pharmacol; 1972 Jan; 44(1):117-39. PubMed ID: 5015032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for separate serotonin and catecholamine compartments in human platelets.
    Smith CC
    Biochim Biophys Acta; 1996 Aug; 1291(1):1-4. PubMed ID: 8781518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet activation by circulating levels of hormones: a possible link in coronary heart disease.
    Ardlie NG; Cameron HA; Garrett J
    Thromb Res; 1984 Nov; 36(4):315-22. PubMed ID: 6523443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biphasic aggregation responses to ADP and epinephrine in some storage pool deficient platelets: relationship to the role of endogenous ADP in platelet aggregation and secretion.
    Lages B; Weiss HJ
    Thromb Haemost; 1980 Jun; 43(2):147-53. PubMed ID: 7455974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
    De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increases in aggregation by and uptake of 5-hydroxytryptamine with platelets from rabbits treated with chlorpromazine.
    Baldacci M; Baldacci M; Bergel TD; Born GV; Hickman M
    Br J Pharmacol; 1980 May; 69(1):113-8. PubMed ID: 7378650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.